Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis

Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis

US Patent 6365165 · Granted Apr 2, 2002

Estimated economic value: $2,824,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

RNA vaccines against infectious diseases2025
Immunogenic compositions comprising Mycobacterium tuberculosis polypeptides and 2025
SARS-CoV-2 RNA vaccine compositions and methods of use2025
Dried nanoparticle compositions2025
Compositions and methods for delivery of RNA2024
Compositions and methods for delivery of RNA2024
Immunogenic compositions comprising Mycobacterium tuberculosis polypeptides and 2024
Single vial vaccine formulations2023
Vaccines comprising Mycobacterium leprae polypeptides for the prevention, treatm2023
Nucleic acid-small diameter and liquid core nanoparticle complexed compositions2023
Compositions and methods for delivery of RNA2023
Compositions and methods for delivery of RNA2023